SEMNUR PHARMACEUTICALS, INC. (SMNR) Operating cash flow 2022–2025
SEMNUR PHARMACEUTICALS, INC. (SMNR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.9MFY2025 · since FY2022: -$426,095 → -$5.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.9M | -20.0% |
| FY2024 | -$4.9M | -672.9% |
| FY2023 | -$632,783 | -48.5% |
| FY2022 | -$426,095 | — |
Source: SEC XBRL filings · For reference only · Not investment advice